Кардиоиммунология нарушений сердечного ритма и проводимости: аутоиммунные и воспалительные механизмы

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323(4):236–41.

PMID: 2195340. https://doi.org/10.1056/nejm199007263230405

2. Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269–85.

PMID: 31969688. https://doi.org/10.1038/s41569-019-0315-x

3. Михайлов Е.Н., Гизатулина Т.П., Лебедев Д.С., Голухова Е.З., Харлап М.С., Лебедева В.К. с соавт. Желудочковые нарушения ритма сердца. Внезапная сердечная смерть. Клинические рекомендации 2025. Российский кардиологический журнал. 2025;30(11):281–378. (Mikhailov EN, Gizatulina TP, Lebedev DS, Golukhova EZ, Kharlap MS, Lebedeva VK et al. 2025 Clinical practice guidelines for ventricular arrhythmias of the heart and sudden cardiac death. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2025;30(11):281–378 (In Russ.)).

EDN: RLJANM. https://doi.org/10.15829/1560-4071-2025-6670

4. Lazzerini PE, Capecchi PL, Laghi-Pasini F, Boutjdir M. Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias. Nat Rev Cardiol. 2017;14(9):521–35.

PMID: 28470179. https://doi.org/10.1038/nrcardio.2017.61

5. Nerbonne JM. Molecular basis of functional myocardial potassium channel diversity. Card Electrophysiol Clin. 2016;8(2):257–73.

PMID: 27261820. https://doi.org/10.1016/j.ccep.2016.01.001

6. Maixent JM, Paganelli F, Scaglione J, Levy S. Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 1998;9(6):612–17.

PMID: 9654226. https://doi.org/10.1111/j.1540-8167.1998.tb00942.x

7. Li J. The role of autoantibodies in arrhythmogenesis. Curr Cardiol Rep. 2020;23(1):3.

PMID: 33241446. https://doi.org/10.1007/s11886-020-01430-x

8. Amin AS, Wilde AA. Genetic control of potassium channels. Card Electrophysiol Clin. 2016;8(2):285–306.

PMID: 27261822. https://doi.org/10.1016/j.ccep.2016.01.003

9. Capecchi PL, Laghi-Pasini F, El-Sherif N, Qu Y, Boutjdir M, Lazzerini PE. Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms. Heart Rhythm. 2019;16(8):1273–80.

PMID: 30772530. https://doi.org/10.1016/j.hrthm.2019.02.017

10. Lazzerini P.E., Cevenini G., Qu Y.S. et al. Risk of QTc Interval prolongation associated with circulating anti-Ro/SSA antibodies among US veterans: An observational cohort study. J Am Heart Assoc. 2021;10(4):e018735.

PMID: 33533258. https://doi.org/10.1161/JAHA.120.018735

11. Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity. 2005;38(1):55–63.

PMID: 15804706. https://doi.org/10.1080/08916930400022954

12. Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S et al. Prevalence of disease-specific antinuclear antibodies in general population: Estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol. 2008;18(2):153–60.

PMID: 18283522. https://doi.org/10.1007/s10165-008-0028-1

13. Tufan AN, Sag S, Oksuz MF, Ermurat S, Coskun BN, Gullulu M et al. Prolonged Tpeak-Tend interval in anti-Ro52 antibody-positive connective tissue diseases. Rheumatol Int. 2017;37(1):67–73.

PMID: 27193468. https://doi.org/10.1007/s00296-016-3488-1

14. Lazzerini PE, Yue Y, Srivastava U, Fabris F, Capecchi PL, Bertolozzi I et al. Arrhythmogenicity of anti-Ro/SSA antibodies in patients with Torsades de Pointes. Circ Arrhythm Electrophysiol. 2016;9(4):e003419.

PMID: 27030700. https://doi.org/10.1161/CIRCEP.115.003419

15. Li J, Seyler C, Wiedmann F, Schmidt C, Schweizer PA, Becker R et al. Anti-KCNQ1 K+ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy. Cardiovasc Res. 2013;98(3):496–503.

PMID: 23447643. https://doi.org/10.1093/cvr/cvt046

16. Maguy A, Mahendran Y, Tardif JC, Busseuil D, Li J. Autoimmune atrial fibrillation. Circulation. 2023;148(6):487–98.

PMID: 37401487. PMCID: PMC10399945. https://doi.org/10.1161/CIRCULATIONAHA.122.062776

17. Grant AO. Cardiac ion channels. Circ Arrhythm Electrophysiol. 2009;2(2):185–94.

PMID: 19808464. https://doi.org/10.1161/CIRCEP.108.789081

18. Korkmaz S, Zitron E, Bangert A, Seyler C, Li S, Hegedus P et al. Provocation of an autoimmune response to cardiac voltage-gated sodium channel NaV1.5 induces cardiac conduction defects in rats. J Am Coll Cardiol. 2013;62(4):340–49.

PMID: 23684688. https://doi.org/10.1016/j.jacc.2013.04.041

19. Restivo M, Kozhevnikov DO, Boutjdir M. Optical mapping of activation patterns in an animal model of congenital heart block. Am J Physiol Heart Circ Physiol. 2001;280(4):1889–95.

PMID: 11247806. https://doi.org/10.1152/ajpheart.2001.280.4.H1889

20. Lee HC, Huang KT, Wang XL, Shen WK. Autoantibodies and cardiac arrhythmias. Heart Rhythm. 2011;8(11):1788–95.

PMID: 21740882. https://doi.org/10.1016/j.hrthm.2011.06.032

21. Миронова Е.С., Миронова Н.А., Шарф Т.В., Ефремов Е.Е., Азьмуко А.А., Молокоедов А.С. с соавт. Аутоантитела к М2-холинорецепторам как потенциальный фактор развития аритмии у больных пароксизмальной формой фибрилляции предсердий. Терапевтический архив. 2019;91(9):101–107. (Mironova ES, Mironova NA, Shari TV, Efremov EE, Azmuko AA, Molokoedov AS et al. Autoantibodies to M2-cholinoreceptors as a potential development factor of arrhythmia in patients with paroxysmal atrial fibrillation. Terapevticheskiy arkhiv = Therapeutic archive. 2019;91(9):101–107 (In Russ.)).

EDN: APHONF. https://doi.org/10.26442/00403660.2019.09.000280

22. Baba A, Yoshikawa T, Fukuda Y, Sugiyama T, Shimada M, Akaishi M et al. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J. 2004;25(13):1108–15.

PMID: 15231368. https://doi.org/10.1016/j.ehj.2004.05.012

23. Hong CM, Zheng QS, Liu XT, Shang FJ, Wang HT, Jiang WR. Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo. Cardiology. 2009;112(3):180–87.

PMID: 18679026. https://doi.org/10.1159/000149152

24. Zou C, Zhang Z, Zhao W, Li G, Ma G, Yang X et al. Predictive value of pre-procedural autoantibodies against M2-muscarinic acetylcholine receptor for recurrence of atrial fibrillation one year after radiofrequency catheter ablation. J Transl Med. 2013;11:7.

PMID: 23294565. PMCID: PMC3551716. https://doi.org/10.1186/1479-5876-11-7

25. Gurses KM, Yalcin MU, Kocyigit D, Kesikli SA, Canpolat U, Yorgun H et al. M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation. Europace. 2015;17(2):239–46.

PMID: 25238749. https://doi.org/10.1093/europace/euu228

26. Ma G, Wu X, Zeng L, Jin J, Liu X, Zhang J, Zhang L. Association of autoantibodies against M2-muscarinic acetylcholine receptor with atrial fibrosis in atrial fibrillation patients. Cardiol Res Pract. 2019;2019:8271871.

PMID: 30863630. https://doi.org/10.1155/2019/8271871

27. Shang L, Zhang L, Shao M, Feng M, Shi J et al. Elevated β1-adrenergic receptor autoantibody levels increase atrial fibrillation susceptibility by promoting atrial fibrosis. Front Physiol. 2020;11:76.

PMID: 32116783. PMCID: PMC7028693. https://doi.org/10.3389/fphys.2020.00076

28. Новикова Д.С., Бекбосынова М.С., Антидзе Т.Я., Лоладзе Н.В., Домогацкий С.П., Голицын С.П. с соавт. Аутоантитела к бета(1)-адренорецепторам у больных с нарушениями ритма сердца: частота выявления и их возможная роль в развитии аритмии. Кардиология. 2004;44(7):17–22. (Novikova DS, Bekbosynova MS, Antidze TYa, Loladze NV, Domogatsky SP, Golitsyn SP et al. Autoantibodies against beta(1)-adrenoreceptors in patients with cardiac rhythm disorders. Prevalence and possible role in development of arrhythmia. Kardiologiya = Cardiology. 2004;44(7):17–22 (In Russ.)). EDN: OJSCQP.

29. Бекбосынова М.С., Никитина Т.Я., Голицын С.П., Новикова Д.С., Лоладзе Н.В., Масенко В.П., Тоневицкий А.Г. Уровень С-реактивного белка и частота выявления аутоантител к β1-адренорецепторам у больных с наджелудочковыми тахиаритмиями. Кардиология. 2006;46(7):55–61. (Bekbosynova MS, Nikitina TYa, Golitsyn SP, Novikova DS, Loladze NV, Masenko VP, Tonevitsky AG. C-reactive protein level and rate of detection of autoantibodies to beta(1)-adrenoreceptors in patients with supraventricular tachyarrhythmias. Kardiologiya = Cardiology. 2006;46(7):55–61 (In Russ.)). PMID: 16883266.

30. Качнов В.А., Кольцов А.В., Тыренко В.В., Сорокина А.А. Роль хронического низкоинтенсивного воспаления и NLRP3 инфламмасомы в развитии и прогрессировании сердечно-сосудистых заболеваний. Доктор.Ру. 2025;24(8):48–56. (Kachnov VA, Koltsov AV, Tyrenko VV, Sorokina AA. The role of chronic low-grade inflammation and NLRP3 inflammasome in the developmeny and progression of cardiovascular diseases. Doctor.Ru. 2025;24(8):48–56 (In Russ.)).

EDN: JWQIDG. https://doi.org/10.31550/1727-2378-2025-24-8-48-56

31. Tilly MJ, Geurts S, Zhu F, Bos MM, Ikram MA, de Maat MPM et al. Autoimmune diseases and new-onset atrial fibrillation: a UK Biobank study. Europace. 2023;25(3):804–11.

PMID: 36546587. https://doi.org/10.1093/europace/euac244

32. Khan D, Ansar Ahmed S. The immune system is a natural target for estrogen action: opposing effects of estrogen in two prototypical autoimmune diseases. Front Immunol. 2016;6:635.

PMID: 26779182. https://doi.org/10.3389/fimmu.2015.00635

33. Empana JP, Lerner I, Valentin E, Folke F, Böttiger B, Gislason G et al. ESCAPE-NET Investigators. Incidence of sudden cardiac death in the European Union. J Am Coll Cardiol. 2022;79(18):1818–27.

PMID: 35512862. https://doi.org/10.1016/j.jacc.2022.02.041

34. Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315–27.

PMID: 30653442. https://doi.org/10.1161/CIRCRESAHA.118.313591

35. Wilhelm M, Kirste W, Kuly S, Amann K, Neuhuber W, Weyand M et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation. Heart Lung Circ. 2006;15(1):30–37.

PMID: 16473788. https://doi.org/10.1016/j.hlc.2005.06.011

36. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res. 1999;44(1):121–31.

PMID: 10615396. https://doi.org/10.1016/s0008-6363(99)00178-9

37. Weintraub NL, Guha A, Taskar V, Elam RE, Chiang AWT, Ley K et al. Cardiovascular manifestations and immunobiology of sarcoidosis. Arterioscler Thromb Vasc Biol. 2026;46(2):e323111.

PMID: 41410048. https://doi.org/10.1161/ATVBAHA.125.323111

38. Figliozzi S, Rojanathagoon T, Karogianni S, Cambini L, Bernardi M, Panico C et al. The risk of cardiovascular death in systemic immune-mediated diseases: A systematic review and meta-analysis. Am J Prev Cardiol. 2025;25:101366.

PMID: 41476998. PMCID: PMC12752519. https://doi.org/10.1016/j.ajpc.2025.101366

39. Ungurean V, Costan DE, Dobos MC, Ouatu A, Morariu PC, Oancea AF et al. Arrhythmias in rheumatoid arthritis: A Call for a multidisciplinary team. Life (Basel). 2025;15(9):1426.

PMID: 41010368. https://doi.org/10.3390/life15091426

40. Bissell LA, Dumitru RB, Erhayiem B, Abignano G, Fent G, Kidambi A et al. Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP. Rheumatology (Oxford). 2019;58(7):1221–26.

PMID: 30690570. PMCID: PMC6587914. https://doi.org/10.1093/rheumatology/key430

41. Morovatdar N, Watts GF, Bondarsahebi Y, Goldani F, Rahmanipour E, Rezaee R, Sahebkar A. Ankylosing spondylitis and risk of cardiac arrhythmia and conduction disorders: A systematic review and meta-analysis. Curr Cardiol Rev. 2021;17(5):e150521193326.

PMID: 33992063. PMCID: PMC8950453. https://doi.org/10.2174/1573403X17666210515164206

42. Simsek H, Sahin M, Akyol A, Akdag S, Ozkol HU, Gumrukcuoglu HA, Gunes Y. Increased risk of atrial and ventricular arrhythmia in long-lasting psoriasis patients. ScientificWorldJournal. 2013;2013:901215.

PMID: 23653531. PMCID: PMC3628657. https://doi.org/10.1155/2013/901215

43. Gu X, Lv H, Wei M, Yeerken M, Lu Y. Autoimmune antibodies in arrhythmia: A narrative review of potential therapeutic targets to prevent overtreatment. Cardiovasc Diagn Ther. 2025;15(4):898–914.

PMID: 40948718. https://doi.org/10.21037/cdt-2025-173

44. Narous M, Nugent Z, Rabinovich-Nikitin I, Kirshenbaum L, Bernstein CN. Cardiac arrhythmia in patients with inflammatory bowel disease: A retrospective, population-based cohort study in Manitoba, Canada. BMJ Open. 2025;15(3):e097687.

PMID: 40118486. https://doi.org/10.1136/bmjopen-2024-097687